Synthesis and functional screening of novel inhibitors targeting the HDAC6 zinc finger ubiquitin-binding domain
Authors:
- 27 December 2024
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 285, 117208
Abstract
No abstract availableKeywords
Funding Information
- Universiteit Gent
- Vlaamse regering
- FWO
This publication has 81 references indexed in Scilit:
- Bortezomib for the Treatment of Hematologic Malignancies: 15 Years LaterDrugs in R&D, 2019
- Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer modelsInternational Journal of Cancer, 2019
- Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresomeThe International Journal of Biochemistry & Cell Biology, 2014
- Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's diseaseEMBO Molecular Medicine, 2012
- From the bench to the bedside: emerging new treatments in multiple myelomaBest Practice & Research Clinical Haematology, 2007
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validationJournal of Computational Chemistry, 2002
- The ubiquitin-proteasome proteolytic pathwayCell, 1994
- Heat shock, stress proteins, chaperones, and proteotoxicityCell, 1991
- WHAT IF: A molecular modeling and drug design programJournal of Molecular Graphics, 1990